The core activity of Novochizol SA is the research and development of technologies for targeted delivery of active pharmaceutical ingredients (APIs) in cells and tissues, particularly in the fields of pharmaceuticals, diagnostics, and medical technology. The company develops products and solutions for various applications, including:
* Drug Formulation: Development of formulations for targeted delivery of APIs
* Covid-19 In Vitro Diagnostics: Development of diagnostic tools for COVID-19
* Aerosols: Development of aerosol products for various applications
* Agrotechnology: Development of solutions for agriculture, including improvement of seed germination and plant growth
* Medical Devices: Development of medical devices, including targeted delivery of botulinum toxin for the treatment of atrial fibrillation.
The company focuses on developing innovative solutions for various industries and applications, with a focus on targeted delivery of APIs and improvement of diagnostic and therapeutic methods.